Medicare Enrolled
Dr. Paul Wawrzynski, M.D.
Cardiovascular Disease · New Castle, PA
Practice pattern: Cardiac & Cardiac
— Practice combining cardiac and cardiac services
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wawrzynski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wawrzynski?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wawrzynski
Dr. Paul Wawrzynski is a cardiovascular disease specialist in New Castle, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Wawrzynski performed 2,959 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Wawrzynski received a total of $32,906 from 52 pharmaceutical and/or device companies across 2107 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wawrzynski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 29% volume in PA
$32,906 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,959
Medicare services
Top 29% in PA for cardiovascular disease
Not available
Unique patients (not deduplicated)
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
530 | $43 | $80 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
457 | $123 | $318 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
285 | $10 | $45 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
214 | $89 | $171 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
202 | $61 | $116 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
193 | $47 | $247 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
177 | $302 | $607 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
165 | $70 | $174 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
152 | $58 | $118 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
148 | $6 | $45 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
87 | $113 | $260 |
| Physician review of home INR testing A physician reviews, interprets, and manages home INR testing results for patients with mechanical heart valves, chronic atrial fibrillation, or venous thromboembolism who meet Medicare coverage criteria. |
72 | $6 | $20 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
54 | $91 | $167 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
47 | $64 | $163 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
47 | $38 | $63 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
29 | $100 | $220 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
26 | $133 | $323 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
20 | $19 | $41 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
14 | $15 | $75 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
14 | $10 | $63 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
13 | $79 | $169 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
13 | $118 | $230 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
15.4% high complexity
37.6% medium
46.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$32,906
Total received (2018-2024)
Avg $4,701/year across 7 years
Top 12% in PA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
2,107
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,731
2023
$4,449
2022
$5,483
2021
$5,453
2020
$3,489
2019
$4,708
2018
$4,593
Payments by company (2024)
E.R. Squibb & Sons, L.L.C.
$584
AstraZeneca Pharmaceuticals LP
$427
PFIZER INC.
$414
SCPHARMACEUTICALS INC.
$359
Novartis Pharmaceuticals Corporation
$328
Janssen Pharmaceuticals, Inc
$292
Boston Scientific Corporation
$240
Merck Sharp & Dohme LLC
$233
Novo Nordisk Inc
$227
Amgen Inc.
$199
Kiniksa Pharmaceuticals International, plc
$180
Bayer Healthcare Pharmaceuticals Inc.
$172
Edwards Lifesciences Corporation
$172
Esperion Therapeutics, Inc.
$158
Abbott Laboratories
$146
Phathom Pharmaceuticals, Inc.
$129
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$98
Boehringer Ingelheim Pharmaceuticals, Inc.
$96
Actelion Pharmaceuticals US, Inc.
$69
Azurity Pharmaceuticals, Inc.
$54
Lexicon Pharmaceuticals, Inc.
$49
CVRx, Inc.
$31
SANOFI-AVENTIS U.S. LLC
$26
Tactile Systems Technology Inc
$22
United Therapeutics Corporation
$17
AltaThera Pharmaceuticals LLC
$8
Top 3 companies account for 30.1% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$3,088
Janssen Pharmaceuticals, Inc
$3,056
Amgen Inc.
$2,946
Novartis Pharmaceuticals Corporation
$2,744
AstraZeneca Pharmaceuticals LP
$2,438
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,677
E.R. Squibb & Sons, L.L.C.
$1,539
Amarin Pharma Inc.
$1,418
SANOFI-AVENTIS U.S. LLC
$1,343
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$1,306
Actelion Pharmaceuticals US, Inc.
$1,149
Novo Nordisk Inc
$1,118
Bayer HealthCare Pharmaceuticals Inc.
$966
Kowa Pharmaceuticals America, Inc.
$837
Esperion Therapeutics, Inc.
$643
Merck Sharp & Dohme LLC
$592
Boston Scientific Corporation
$491
Bayer Healthcare Pharmaceuticals Inc.
$457
SCPHARMACEUTICALS INC.
$441
Impulse Dynamics (USA) Inc.
$314
Kiniksa Pharmaceuticals, Ltd.
$291
Gilead Sciences, Inc.
$285
Lexicon Pharmaceuticals, Inc.
$258
Relypsa, Inc.
$253
Regeneron Healthcare Solutions, Inc.
$248
United Therapeutics Corporation
$245
CVRx, Inc.
$222
Edwards Lifesciences Corporation
$198
Abbott Laboratories
$194
AltaThera Pharmaceuticals LLC
$187
Kiniksa Pharmaceuticals International, plc
$180
Vifor Pharma, Inc.
$173
Allergan Inc.
$166
BOSTON SCIENTIFIC CORPORATION
$149
ATRICURE, INC.
$148
AtriCure, Inc.
$145
Lundbeck LLC
$138
Phathom Pharmaceuticals, Inc.
$129
Tactile Systems Technology Inc
$113
Alnylam Pharmaceuticals Inc.
$103
Arbor Pharmaceuticals, Inc.
$78
GENZYME CORPORATION
$78
Azurity Pharmaceuticals, Inc.
$73
ARBOR PHARMACEUTICALS, INC.
$61
Corcept Therapeutics
$58
ABIOMED
$44
Preventice Services, LLC
$27
Daiichi Sankyo Inc.
$27
Kestra Medical Technology Services, Inc.
$24
Amryt Pharma Holdings Ltd
$17
Merck Sharp & Dohme Corporation
$16
Medtronic Vascular, Inc.
$15
Top 3 companies account for 27.6% of all-time payments
Associated products mentioned in payments ›
ACC2 CARDIAC CRYOSURGICAL SYSTEM · ACC2 Cardiac Cryosurgical System · ATRICURE ATRICLIP LAA EXCLUSION · Adempas · Arcalyst · Assure WCD · AtriCure AtriClip LAA Exclusion System · BG Mini Plus · BRILINTA · BYDUREON · BYSTOLIC · Barostim Neo System · CAMZYOS · CHANTIX · CONFIRM RX · Corlanor · DUPIXENT · EDARBI · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edarbi · Edarbyclor · FARXIGA · FUROSCIX · Flexitouch Plus · GALLANT · GENERAL BRADY · GENERAL BRADY · Horizant · INGEVITY · INJECTAFER · Impella · Inpefa · JARDIANCE · JOT DX · Kerendia · Korlym · LEQVIO · LUX-Dx Insertable Cardiac Monitor · Letairis · LifeVest · Livalo · MITRACLIP · MULTAQ · MYALEPT · NEXLETOL · NEXLIZET · NORTHERA · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · OPTIMIZER · ORENITRAM · Optimizer · Optimizer Smart System · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · RYBELSUS · Repatha · Reveal LINQ · Rybelsus · SAPIEN 3 Ultra RESILIA · STEGLATRO · Sotalol Hydrochloride · TYVASO · UPTRAVI · VERQUVO · VIAGRA · VOQUEZNA · VYNDAQEL · Vascepa · Veltassa · Verquvo · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WINREVAIR · Wegovy · XARELTO
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Cardiologists in nearby ZIP areas
57
County median income
$60,779
Nearest hospital to ZIP centroid (approximate)
UPMC JAMESON
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wawrzynski is a cardiac & cardiac specialist, with above-average Medicare volume (top 29% in PA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wawrzynski experienced with regadenoson injection (lexiscan) for heart stress test?
Based on Medicare claims data, Dr. Wawrzynski performed 530 regadenoson injection (lexiscan) for heart stress test services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Wawrzynski receive payments from pharmaceutical companies?
Yes. Dr. Wawrzynski received a total of $32,906 from 52 companies across 2,107 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wawrzynski's costs compare to other cardiologists in New Castle?
Dr. Wawrzynski's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wawrzynski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in New Castle
Browse cardiologists in New Castle ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in PA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in PA
Which PA cardiologists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology